| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mitochondria, Heart | 33 | 2022 | 66 | 9.600 |
Why?
|
| Mitochondria | 22 | 2023 | 454 | 5.650 |
Why?
|
| Myocardial Reperfusion Injury | 17 | 2020 | 54 | 4.620 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 19 | 2022 | 33 | 4.400 |
Why?
|
| Myocytes, Cardiac | 18 | 2023 | 165 | 3.390 |
Why?
|
| Mitochondrial Membranes | 9 | 2023 | 38 | 2.960 |
Why?
|
| Mitochondrial Swelling | 5 | 2022 | 8 | 2.940 |
Why?
|
| Heart | 14 | 2023 | 178 | 2.730 |
Why?
|
| Cardiotonic Agents | 6 | 2018 | 35 | 2.680 |
Why?
|
| Myocardium | 18 | 2020 | 224 | 2.170 |
Why?
|
| Myocardial Ischemia | 10 | 2017 | 72 | 2.160 |
Why?
|
| Rats | 47 | 2022 | 3261 | 2.030 |
Why?
|
| Electron Transport | 6 | 2019 | 38 | 1.940 |
Why?
|
| Myocardial Infarction | 6 | 2018 | 221 | 1.910 |
Why?
|
| Animals | 75 | 2023 | 14307 | 1.850 |
Why?
|
| Cyclophilins | 3 | 2018 | 7 | 1.820 |
Why?
|
| Angiotensin II | 8 | 2019 | 92 | 1.790 |
Why?
|
| Electron Transport Complex I | 6 | 2019 | 20 | 1.760 |
Why?
|
| Reactive Oxygen Species | 10 | 2019 | 416 | 1.760 |
Why?
|
| GTP Phosphohydrolases | 3 | 2023 | 29 | 1.730 |
Why?
|
| Rats, Sprague-Dawley | 28 | 2021 | 1534 | 1.560 |
Why?
|
| Electron Transport Chain Complex Proteins | 2 | 2020 | 12 | 1.530 |
Why?
|
| Cardiomegaly | 8 | 2014 | 39 | 1.510 |
Why?
|
| Ventricular Remodeling | 5 | 2014 | 59 | 1.490 |
Why?
|
| Osmotic Pressure | 3 | 2018 | 20 | 1.440 |
Why?
|
| Calcium | 14 | 2023 | 445 | 1.370 |
Why?
|
| Energy Metabolism | 9 | 2022 | 160 | 1.360 |
Why?
|
| Models, Biological | 7 | 2020 | 642 | 1.350 |
Why?
|
| Cyclic N-Oxides | 3 | 2016 | 17 | 1.220 |
Why?
|
| Alzheimer Disease | 3 | 2023 | 881 | 1.170 |
Why?
|
| Computer Simulation | 2 | 2019 | 347 | 1.160 |
Why?
|
| Cell Death | 6 | 2019 | 260 | 1.070 |
Why?
|
| Oxidative Stress | 8 | 2023 | 874 | 1.050 |
Why?
|
| Membrane Potential, Mitochondrial | 7 | 2022 | 71 | 1.050 |
Why?
|
| Heart Failure | 4 | 2018 | 230 | 1.020 |
Why?
|
| Endothelial Cells | 3 | 2023 | 296 | 1.020 |
Why?
|
| Cardiolipins | 3 | 2023 | 11 | 1.010 |
Why?
|
| Metformin | 3 | 2015 | 64 | 1.000 |
Why?
|
| Phospholipids | 6 | 2023 | 68 | 0.990 |
Why?
|
| Edema | 1 | 2023 | 20 | 0.940 |
Why?
|
| PPAR alpha | 2 | 2015 | 42 | 0.930 |
Why?
|
| Adenine Nucleotides | 1 | 2022 | 6 | 0.880 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 2 | 2018 | 13 | 0.830 |
Why?
|
| Cardiomyopathies | 3 | 2018 | 55 | 0.830 |
Why?
|
| Electron Transport Complex II | 2 | 2018 | 7 | 0.800 |
Why?
|
| Calcium Signaling | 3 | 2017 | 95 | 0.790 |
Why?
|
| Heart Diseases | 2 | 2014 | 99 | 0.780 |
Why?
|
| Muscle, Skeletal | 3 | 2022 | 257 | 0.770 |
Why?
|
| Male | 38 | 2021 | 18870 | 0.770 |
Why?
|
| Free Radical Scavengers | 4 | 2014 | 65 | 0.760 |
Why?
|
| Electron Transport Complex III | 2 | 2017 | 12 | 0.760 |
Why?
|
| Disease | 1 | 2020 | 18 | 0.750 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2014 | 122 | 0.740 |
Why?
|
| Mitochondrial ADP, ATP Translocases | 2 | 2019 | 6 | 0.740 |
Why?
|
| Health | 1 | 2020 | 28 | 0.740 |
Why?
|
| Receptors, Angiotensin | 1 | 2019 | 11 | 0.710 |
Why?
|
| Diabetes Mellitus, Experimental | 5 | 2016 | 87 | 0.700 |
Why?
|
| Renin-Angiotensin System | 1 | 2019 | 33 | 0.690 |
Why?
|
| Signal Transduction | 10 | 2019 | 1802 | 0.690 |
Why?
|
| Losartan | 3 | 2018 | 31 | 0.680 |
Why?
|
| Muscle Contraction | 2 | 2016 | 63 | 0.680 |
Why?
|
| Cell Membrane Permeability | 1 | 2018 | 49 | 0.630 |
Why?
|
| Cell Line | 7 | 2021 | 1289 | 0.630 |
Why?
|
| Oxidative Phosphorylation | 5 | 2021 | 49 | 0.620 |
Why?
|
| Atherosclerosis | 1 | 2018 | 131 | 0.600 |
Why?
|
| Cyclosporine | 3 | 2017 | 26 | 0.590 |
Why?
|
| Humans | 26 | 2023 | 34853 | 0.570 |
Why?
|
| Drug Discovery | 1 | 2017 | 77 | 0.560 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2014 | 49 | 0.560 |
Why?
|
| Adenylate Kinase | 2 | 2015 | 13 | 0.560 |
Why?
|
| Mitochondria, Muscle | 1 | 2015 | 16 | 0.550 |
Why?
|
| Physiology | 1 | 2015 | 14 | 0.530 |
Why?
|
| Enzyme Activators | 1 | 2015 | 10 | 0.530 |
Why?
|
| Sirtuin 3 | 1 | 2015 | 5 | 0.530 |
Why?
|
| Leptin | 7 | 2012 | 115 | 0.520 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2014 | 31 | 0.520 |
Why?
|
| ras Proteins | 1 | 2015 | 49 | 0.510 |
Why?
|
| Myocardial Contraction | 6 | 2020 | 47 | 0.480 |
Why?
|
| Ischemic Preconditioning, Myocardial | 5 | 2017 | 13 | 0.480 |
Why?
|
| Ion Channels | 2 | 2004 | 69 | 0.470 |
Why?
|
| Hypoglycemic Agents | 2 | 2012 | 152 | 0.460 |
Why?
|
| Antioxidants | 2 | 2017 | 386 | 0.440 |
Why?
|
| Renin | 1 | 2012 | 29 | 0.430 |
Why?
|
| Cell Respiration | 5 | 2022 | 33 | 0.420 |
Why?
|
| Endothelin-1 | 5 | 2012 | 54 | 0.420 |
Why?
|
| Oxygen Consumption | 5 | 2018 | 98 | 0.390 |
Why?
|
| Adenosine Triphosphate | 10 | 2021 | 180 | 0.390 |
Why?
|
| Spiro Compounds | 3 | 2018 | 10 | 0.380 |
Why?
|
| Lactones | 3 | 2018 | 20 | 0.380 |
Why?
|
| Fatty Acids | 2 | 2023 | 118 | 0.370 |
Why?
|
| beta-Thalassemia | 2 | 2004 | 7 | 0.370 |
Why?
|
| Mitochondrial Proteins | 1 | 2010 | 96 | 0.360 |
Why?
|
| Cardiovascular Agents | 1 | 2009 | 20 | 0.360 |
Why?
|
| Blood Platelets | 2 | 2004 | 74 | 0.350 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2009 | 27 | 0.340 |
Why?
|
| Receptor, Angiotensin, Type 2 | 2 | 2019 | 6 | 0.340 |
Why?
|
| Receptor, Angiotensin, Type 1 | 3 | 2019 | 23 | 0.340 |
Why?
|
| Bezafibrate | 2 | 2018 | 4 | 0.330 |
Why?
|
| Disease Models, Animal | 9 | 2017 | 1300 | 0.330 |
Why?
|
| Blotting, Western | 6 | 2017 | 834 | 0.310 |
Why?
|
| Cell Size | 2 | 2012 | 42 | 0.310 |
Why?
|
| Guanidines | 4 | 2010 | 17 | 0.310 |
Why?
|
| Sulfones | 4 | 2010 | 40 | 0.300 |
Why?
|
| Echocardiography | 3 | 2018 | 144 | 0.300 |
Why?
|
| Barth Syndrome | 2 | 2017 | 2 | 0.290 |
Why?
|
| Citrate (si)-Synthase | 3 | 2015 | 12 | 0.290 |
Why?
|
| rhoA GTP-Binding Protein | 4 | 2011 | 30 | 0.280 |
Why?
|
| Cells, Cultured | 12 | 2015 | 1442 | 0.280 |
Why?
|
| Endodeoxyribonucleases | 3 | 2015 | 29 | 0.280 |
Why?
|
| Phosphorylation | 8 | 2014 | 878 | 0.270 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2016 | 60 | 0.270 |
Why?
|
| Deoxyglucose | 3 | 2021 | 19 | 0.270 |
Why?
|
| Infarction | 1 | 2004 | 1 | 0.260 |
Why?
|
| Gene Expression Regulation | 4 | 2018 | 968 | 0.260 |
Why?
|
| Rats, Inbred F344 | 2 | 2015 | 228 | 0.260 |
Why?
|
| Erythrocyte Membrane | 1 | 2004 | 20 | 0.250 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2015 | 117 | 0.250 |
Why?
|
| Actins | 5 | 2009 | 142 | 0.240 |
Why?
|
| Phosphocreatine | 6 | 1987 | 10 | 0.240 |
Why?
|
| Erythrocytes | 1 | 2004 | 107 | 0.240 |
Why?
|
| Linoleic Acid | 1 | 2023 | 7 | 0.240 |
Why?
|
| Permeability | 3 | 2017 | 67 | 0.230 |
Why?
|
| Apoptosis | 4 | 2018 | 1317 | 0.230 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 4 | 2012 | 93 | 0.230 |
Why?
|
| Ischemic Preconditioning | 1 | 2003 | 48 | 0.220 |
Why?
|
| Mammals | 1 | 2023 | 96 | 0.220 |
Why?
|
| Hypertrophy | 4 | 2012 | 31 | 0.220 |
Why?
|
| Proto-Oncogene Proteins c-akt | 5 | 2017 | 245 | 0.210 |
Why?
|
| Electron Transport Complex IV | 2 | 2015 | 35 | 0.210 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2021 | 17 | 0.210 |
Why?
|
| Blood Vessels | 1 | 2021 | 32 | 0.210 |
Why?
|
| Gene Knockdown Techniques | 2 | 2019 | 161 | 0.200 |
Why?
|
| Enzyme Activation | 5 | 2015 | 423 | 0.200 |
Why?
|
| Heart Ventricles | 4 | 2011 | 121 | 0.200 |
Why?
|
| Phosphatidylethanolamines | 1 | 2021 | 22 | 0.200 |
Why?
|
| Colonic Neoplasms | 2 | 2021 | 181 | 0.200 |
Why?
|
| Neoplasms | 1 | 2011 | 1033 | 0.200 |
Why?
|
| Deoxyribonucleases | 2 | 2015 | 25 | 0.200 |
Why?
|
| Nerve Degeneration | 1 | 2021 | 101 | 0.200 |
Why?
|
| Cytoskeleton | 2 | 2020 | 98 | 0.200 |
Why?
|
| Propofol | 2 | 2000 | 8 | 0.200 |
Why?
|
| Lipid Peroxidation | 1 | 2021 | 131 | 0.190 |
Why?
|
| Peptide Fragments | 1 | 2023 | 298 | 0.190 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 3 | 2018 | 37 | 0.190 |
Why?
|
| Glutathione | 1 | 2021 | 160 | 0.190 |
Why?
|
| 2-Propanol | 1 | 2020 | 4 | 0.190 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2012 | 195 | 0.190 |
Why?
|
| Chromatography, Liquid | 1 | 2021 | 140 | 0.190 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 605 | 0.190 |
Why?
|
| Rotenone | 1 | 2020 | 18 | 0.190 |
Why?
|
| Phospholipid Transfer Proteins | 1 | 2019 | 6 | 0.190 |
Why?
|
| Biophysical Phenomena | 1 | 2019 | 21 | 0.180 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2021 | 173 | 0.180 |
Why?
|
| Oxidation-Reduction | 2 | 2018 | 407 | 0.180 |
Why?
|
| Protein Binding | 2 | 2015 | 913 | 0.170 |
Why?
|
| Protein Multimerization | 1 | 2020 | 97 | 0.170 |
Why?
|
| Sirtuins | 1 | 2018 | 12 | 0.170 |
Why?
|
| Microtubules | 1 | 2020 | 113 | 0.170 |
Why?
|
| Necrosis | 2 | 2018 | 45 | 0.170 |
Why?
|
| RNA Interference | 1 | 2019 | 225 | 0.170 |
Why?
|
| Hela Cells | 1 | 2019 | 344 | 0.170 |
Why?
|
| Recovery of Function | 3 | 2014 | 89 | 0.170 |
Why?
|
| Acetylation | 1 | 2018 | 94 | 0.170 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2019 | 69 | 0.170 |
Why?
|
| Superoxide Dismutase | 2 | 2017 | 149 | 0.170 |
Why?
|
| Coronary Disease | 6 | 1989 | 113 | 0.170 |
Why?
|
| Nitric Oxide | 2 | 2011 | 287 | 0.160 |
Why?
|
| Acute Disease | 1 | 2018 | 141 | 0.160 |
Why?
|
| Cell Nucleus | 4 | 2012 | 351 | 0.160 |
Why?
|
| MAP Kinase Signaling System | 3 | 2017 | 162 | 0.160 |
Why?
|
| Porosity | 1 | 2018 | 32 | 0.160 |
Why?
|
| Ethanol | 1 | 2020 | 188 | 0.160 |
Why?
|
| Protein Kinase C-delta | 1 | 2017 | 14 | 0.160 |
Why?
|
| Lipid Metabolism | 1 | 2018 | 109 | 0.160 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2017 | 14 | 0.160 |
Why?
|
| tert-Butylhydroperoxide | 1 | 2017 | 5 | 0.160 |
Why?
|
| Acyl-CoA Dehydrogenase, Long-Chain | 2 | 2015 | 4 | 0.160 |
Why?
|
| RNA, Small Interfering | 1 | 2019 | 391 | 0.160 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2019 | 229 | 0.150 |
Why?
|
| rho GTP-Binding Proteins | 2 | 2007 | 22 | 0.150 |
Why?
|
| Inflammation | 1 | 2021 | 577 | 0.150 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2018 | 137 | 0.150 |
Why?
|
| Mice | 5 | 2019 | 5668 | 0.150 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2015 | 984 | 0.140 |
Why?
|
| Amides | 3 | 2012 | 66 | 0.140 |
Why?
|
| Neurodegenerative Diseases | 1 | 2017 | 119 | 0.140 |
Why?
|
| Cell Line, Tumor | 2 | 2019 | 2128 | 0.140 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2017 | 162 | 0.140 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2007 | 184 | 0.140 |
Why?
|
| Immunoblotting | 1 | 2015 | 170 | 0.140 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2007 | 127 | 0.130 |
Why?
|
| Deoxyribonuclease I | 1 | 2015 | 25 | 0.130 |
Why?
|
| L-Lactate Dehydrogenase | 2 | 2012 | 59 | 0.130 |
Why?
|
| Pyrones | 1 | 2015 | 7 | 0.130 |
Why?
|
| Models, Cardiovascular | 2 | 2007 | 53 | 0.130 |
Why?
|
| Group Processes | 1 | 2015 | 21 | 0.130 |
Why?
|
| Chronic Disease | 1 | 2018 | 469 | 0.130 |
Why?
|
| Tyrosine | 2 | 2012 | 109 | 0.130 |
Why?
|
| Potassium Channels | 2 | 2006 | 73 | 0.130 |
Why?
|
| Oxygen | 2 | 2014 | 193 | 0.130 |
Why?
|
| Oxidants | 1 | 2015 | 43 | 0.130 |
Why?
|
| Societies, Medical | 1 | 2015 | 62 | 0.130 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2015 | 65 | 0.130 |
Why?
|
| DNA Fragmentation | 1 | 2015 | 91 | 0.130 |
Why?
|
| Career Choice | 1 | 2015 | 44 | 0.130 |
Why?
|
| Biphenyl Compounds | 1 | 2015 | 52 | 0.130 |
Why?
|
| Thiophenes | 1 | 2015 | 31 | 0.130 |
Why?
|
| Cell Survival | 1 | 2018 | 818 | 0.130 |
Why?
|
| Adenocarcinoma | 1 | 2017 | 239 | 0.130 |
Why?
|
| rho-Associated Kinases | 3 | 2009 | 30 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2014 | 8 | 0.130 |
Why?
|
| Rats, Wistar | 4 | 2003 | 202 | 0.130 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2014 | 109 | 0.120 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2015 | 160 | 0.120 |
Why?
|
| Perfusion | 5 | 2014 | 31 | 0.120 |
Why?
|
| Hypothermia | 1 | 2013 | 14 | 0.120 |
Why?
|
| Sirtuin 1 | 1 | 2014 | 32 | 0.120 |
Why?
|
| Female | 8 | 2018 | 19873 | 0.120 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2014 | 63 | 0.120 |
Why?
|
| Hydrogen Peroxide | 1 | 2014 | 181 | 0.120 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2013 | 26 | 0.120 |
Why?
|
| Microscopy, Confocal | 2 | 2017 | 210 | 0.120 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 756 | 0.120 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2015 | 180 | 0.120 |
Why?
|
| Transcription Factors | 4 | 2015 | 653 | 0.110 |
Why?
|
| Polymerase Chain Reaction | 2 | 2017 | 430 | 0.110 |
Why?
|
| Age Factors | 1 | 2015 | 1007 | 0.110 |
Why?
|
| Oxazoles | 1 | 2012 | 19 | 0.110 |
Why?
|
| Fumarates | 1 | 2012 | 11 | 0.110 |
Why?
|
| Peroxynitrous Acid | 1 | 2011 | 5 | 0.110 |
Why?
|
| Ouabain | 1 | 2011 | 15 | 0.110 |
Why?
|
| Myocardial Reperfusion | 2 | 2004 | 10 | 0.100 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2014 | 200 | 0.100 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2011 | 46 | 0.100 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2011 | 91 | 0.100 |
Why?
|
| Cardiovascular Diseases | 1 | 2017 | 628 | 0.100 |
Why?
|
| Aging | 1 | 2015 | 639 | 0.100 |
Why?
|
| Myosins | 2 | 2016 | 25 | 0.100 |
Why?
|
| Treatment Outcome | 1 | 2015 | 1349 | 0.100 |
Why?
|
| Biomedical Research | 1 | 2015 | 371 | 0.100 |
Why?
|
| Puerto Rico | 1 | 2015 | 1352 | 0.090 |
Why?
|
| RNA, Messenger | 3 | 2015 | 1152 | 0.090 |
Why?
|
| Tubulin | 2 | 2014 | 80 | 0.090 |
Why?
|
| NF-kappa B | 1 | 2012 | 306 | 0.090 |
Why?
|
| Ribonucleotides | 1 | 2009 | 4 | 0.090 |
Why?
|
| Voltage-Dependent Anion Channels | 1 | 2009 | 4 | 0.090 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 4 | 2012 | 90 | 0.090 |
Why?
|
| Aminoimidazole Carboxamide | 1 | 2009 | 4 | 0.090 |
Why?
|
| Rabbits | 4 | 1998 | 278 | 0.090 |
Why?
|
| Reperfusion Injury | 1 | 2009 | 53 | 0.090 |
Why?
|
| Body Weight | 2 | 2016 | 404 | 0.090 |
Why?
|
| Membrane Potentials | 2 | 2006 | 213 | 0.080 |
Why?
|
| Morpholines | 1 | 2009 | 65 | 0.080 |
Why?
|
| Immunoprecipitation | 1 | 2009 | 126 | 0.080 |
Why?
|
| Chromones | 1 | 2009 | 51 | 0.080 |
Why?
|
| Flavonoids | 1 | 2009 | 78 | 0.080 |
Why?
|
| Cardioplegic Solutions | 1 | 1987 | 2 | 0.080 |
Why?
|
| Apoptosis Inducing Factor | 1 | 2007 | 7 | 0.080 |
Why?
|
| Organ Size | 2 | 2005 | 148 | 0.080 |
Why?
|
| Caveolae | 1 | 2007 | 8 | 0.080 |
Why?
|
| Adenosine Diphosphate | 2 | 2004 | 17 | 0.080 |
Why?
|
| Decanoic Acids | 2 | 2006 | 2 | 0.080 |
Why?
|
| Hydroxy Acids | 2 | 2006 | 2 | 0.080 |
Why?
|
| Diazoxide | 2 | 2006 | 5 | 0.080 |
Why?
|
| Estrogens | 1 | 2008 | 190 | 0.080 |
Why?
|
| Sex Characteristics | 1 | 2008 | 213 | 0.080 |
Why?
|
| Estradiol | 1 | 2008 | 244 | 0.070 |
Why?
|
| Receptors, Purinergic P1 | 1 | 2006 | 7 | 0.070 |
Why?
|
| Autocrine Communication | 1 | 2006 | 10 | 0.070 |
Why?
|
| NF-E2-Related Factor 1 | 1 | 2006 | 1 | 0.070 |
Why?
|
| Vasoconstrictor Agents | 1 | 2006 | 38 | 0.070 |
Why?
|
| Animals, Newborn | 4 | 2009 | 323 | 0.070 |
Why?
|
| Glycerophosphates | 2 | 1986 | 3 | 0.070 |
Why?
|
| Membrane Lipids | 2 | 1986 | 31 | 0.070 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2006 | 73 | 0.070 |
Why?
|
| Intracellular Membranes | 1 | 2004 | 34 | 0.070 |
Why?
|
| Time Factors | 4 | 2011 | 1681 | 0.060 |
Why?
|
| Spectrin | 1 | 2004 | 4 | 0.060 |
Why?
|
| Profilins | 1 | 2004 | 2 | 0.060 |
Why?
|
| Actinin | 1 | 2004 | 7 | 0.060 |
Why?
|
| RNA-Binding Proteins | 1 | 2006 | 145 | 0.060 |
Why?
|
| Anion Exchange Protein 1, Erythrocyte | 1 | 2004 | 4 | 0.060 |
Why?
|
| Ankyrins | 1 | 2004 | 6 | 0.060 |
Why?
|
| Gelsolin | 1 | 2004 | 4 | 0.060 |
Why?
|
| Tropomyosin | 1 | 2004 | 13 | 0.060 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2004 | 7 | 0.060 |
Why?
|
| Microfilament Proteins | 1 | 2004 | 64 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2006 | 420 | 0.060 |
Why?
|
| Fluoresceins | 2 | 2017 | 27 | 0.060 |
Why?
|
| Cell Shape | 2 | 2014 | 35 | 0.060 |
Why?
|
| Cytoskeletal Proteins | 1 | 2004 | 97 | 0.060 |
Why?
|
| Osmolar Concentration | 1 | 2003 | 55 | 0.060 |
Why?
|
| Phosphoproteins | 1 | 2004 | 154 | 0.060 |
Why?
|
| Child | 2 | 2004 | 2875 | 0.050 |
Why?
|
| Spectrometry, Mass, Secondary Ion | 1 | 2021 | 2 | 0.050 |
Why?
|
| Carbolines | 1 | 2021 | 13 | 0.050 |
Why?
|
| Brain | 2 | 2021 | 1268 | 0.050 |
Why?
|
| Glycolysis | 1 | 2021 | 66 | 0.050 |
Why?
|
| Heart Arrest, Induced | 1 | 2000 | 3 | 0.050 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 2000 | 2 | 0.050 |
Why?
|
| Soybean Oil | 1 | 2000 | 3 | 0.050 |
Why?
|
| Emulsions | 1 | 2000 | 31 | 0.050 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2012 | 54 | 0.050 |
Why?
|
| Cell Enlargement | 2 | 2012 | 5 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2015 | 1530 | 0.050 |
Why?
|
| Adolescent | 2 | 2004 | 5035 | 0.040 |
Why?
|
| Rats, Inbred Strains | 5 | 1989 | 132 | 0.040 |
Why?
|
| Analysis of Variance | 1 | 2000 | 528 | 0.040 |
Why?
|
| Calcium Channels | 1 | 1998 | 72 | 0.040 |
Why?
|
| Benzophenanthridines | 1 | 2017 | 9 | 0.040 |
Why?
|
| Pyridines | 2 | 2009 | 113 | 0.040 |
Why?
|
| Rhodamines | 1 | 2017 | 20 | 0.040 |
Why?
|
| Photochemistry | 1 | 2017 | 61 | 0.040 |
Why?
|
| Up-Regulation | 2 | 2011 | 490 | 0.040 |
Why?
|
| Receptors, Leptin | 2 | 2006 | 13 | 0.040 |
Why?
|
| Protein Carbonylation | 1 | 2016 | 8 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 1 | 2017 | 240 | 0.040 |
Why?
|
| Isoenzymes | 2 | 2009 | 149 | 0.040 |
Why?
|
| Myosin Heavy Chains | 1 | 2016 | 19 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2017 | 485 | 0.030 |
Why?
|
| Acyltransferases | 1 | 2015 | 21 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2021 | 1149 | 0.030 |
Why?
|
| Receptors, Cell Surface | 2 | 2006 | 135 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 105 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2015 | 126 | 0.030 |
Why?
|
| Kidney Tubules | 1 | 2015 | 28 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2014 | 55 | 0.030 |
Why?
|
| Ventricular Pressure | 1 | 2014 | 8 | 0.030 |
Why?
|
| Lipid Metabolism, Inborn Errors | 1 | 2013 | 3 | 0.030 |
Why?
|
| Mitochondrial Diseases | 1 | 2013 | 16 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2015 | 164 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2016 | 333 | 0.030 |
Why?
|
| Muscular Diseases | 1 | 2013 | 20 | 0.030 |
Why?
|
| Cold Temperature | 1 | 2013 | 39 | 0.030 |
Why?
|
| Ventricular Function, Left | 1 | 2014 | 104 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2015 | 392 | 0.030 |
Why?
|
| Neurons | 1 | 2021 | 1130 | 0.030 |
Why?
|
| Splenectomy | 1 | 2003 | 7 | 0.030 |
Why?
|
| Platelet Aggregation | 1 | 2003 | 17 | 0.030 |
Why?
|
| Complement Activation | 1 | 2003 | 13 | 0.030 |
Why?
|
| Antigen-Antibody Complex | 1 | 2003 | 19 | 0.030 |
Why?
|
| Immunoglobulin A | 1 | 2003 | 58 | 0.030 |
Why?
|
| Molecular Weight | 1 | 2003 | 161 | 0.030 |
Why?
|
| Proteomics | 1 | 2015 | 302 | 0.030 |
Why?
|
| Immunoglobulin M | 1 | 2003 | 81 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2008 | 342 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2013 | 137 | 0.030 |
Why?
|
| Phenotype | 1 | 2014 | 650 | 0.030 |
Why?
|
| Enzyme Induction | 1 | 2011 | 48 | 0.030 |
Why?
|
| Superoxides | 1 | 2011 | 51 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2015 | 366 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2003 | 232 | 0.030 |
Why?
|
| Janus Kinase 2 | 1 | 2011 | 31 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2011 | 52 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2013 | 897 | 0.020 |
Why?
|
| DNA Primers | 1 | 2011 | 269 | 0.020 |
Why?
|
| Peptides | 1 | 2003 | 308 | 0.020 |
Why?
|
| Cofilin 2 | 1 | 2009 | 1 | 0.020 |
Why?
|
| S-Nitroso-N-Acetylpenicillamine | 1 | 2009 | 2 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2011 | 396 | 0.020 |
Why?
|
| Cyclic GMP | 1 | 2009 | 44 | 0.020 |
Why?
|
| Nitric Oxide Synthase | 1 | 2009 | 103 | 0.020 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2008 | 11 | 0.020 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2008 | 33 | 0.020 |
Why?
|
| Phenylephrine | 1 | 2008 | 34 | 0.020 |
Why?
|
| Base Sequence | 1 | 2011 | 932 | 0.020 |
Why?
|
| Protein Transport | 1 | 2009 | 286 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2008 | 97 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2008 | 94 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2008 | 173 | 0.020 |
Why?
|
| Membrane Microdomains | 1 | 2007 | 46 | 0.020 |
Why?
|
| Thiazolidines | 1 | 2006 | 4 | 0.020 |
Why?
|
| ADP Ribose Transferases | 1 | 2006 | 5 | 0.020 |
Why?
|
| Actin Depolymerizing Factors | 1 | 2006 | 3 | 0.020 |
Why?
|
| Botulinum Toxins | 1 | 2006 | 9 | 0.020 |
Why?
|
| Leucine | 1 | 2006 | 28 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1987 | 281 | 0.020 |
Why?
|
| Cholesterol | 1 | 2007 | 194 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2017 | 1426 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2006 | 185 | 0.020 |
Why?
|
| Adipocytes | 1 | 2006 | 54 | 0.020 |
Why?
|
| Portal Vein | 1 | 2005 | 4 | 0.020 |
Why?
|
| Culture Media | 1 | 2005 | 84 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2005 | 110 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2005 | 136 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2006 | 282 | 0.020 |
Why?
|
| Magnesium | 1 | 1995 | 95 | 0.020 |
Why?
|
| Cell Membrane | 2 | 1986 | 360 | 0.010 |
Why?
|
| Acyl Coenzyme A | 1 | 2002 | 2 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 1992 | 20 | 0.010 |
Why?
|
| Chromatography, Thin Layer | 2 | 1986 | 37 | 0.010 |
Why?
|
| Dogs | 2 | 1986 | 138 | 0.010 |
Why?
|
| Peptidylprolyl Isomerase | 1 | 1998 | 10 | 0.010 |
Why?
|
| Obesity | 1 | 2006 | 965 | 0.010 |
Why?
|
| Nucleotidases | 1 | 1986 | 1 | 0.010 |
Why?
|
| Depression, Chemical | 1 | 1986 | 4 | 0.010 |
Why?
|
| 5'-Nucleotidase | 1 | 1986 | 7 | 0.010 |
Why?
|
| Phosphates | 1 | 1986 | 49 | 0.010 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 1986 | 33 | 0.010 |
Why?
|
| Blood Pressure | 1 | 1986 | 613 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1989 | 186 | 0.010 |
Why?
|
| Kinetics | 1 | 1986 | 650 | 0.000 |
Why?
|